Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1 integrin monoclonal antibody (volociximab) in cancer patients
Work
Year: 2009
Type: article
Institutions The University of Texas Health Science Center at San Antonio, South Texas Accelerated Research Therapeutics
Cites: 31
Cited by: 31
Related to: 10
FWCI: 2.51
Citation percentile (by year/subfield): 90.15
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed